Abstract
The formation of chiral compounds during the synthesis of new drugs and related substances, which are administered clinically in the form of racemic mixture, is amply described in the literature. The therapeutic activity of these compounds is strongly dependent on their spatial rearrangement, which leads to different pharmacodynamic and pharmacokinetic properties, where one isomer may pro…